tiprankstipranks
Trending News
More News >
Arteris (AIP)
NASDAQ:AIP
US Market
Advertisement

Arteris (AIP) AI Stock Analysis

Compare
327 Followers

Top Page

AIP

Arteris

(NASDAQ:AIP)

Rating:51Neutral
Price Target:
$10.00
▲(5.49% Upside)
Arteris' overall stock score is primarily influenced by its financial performance challenges, including negative profitability and cash flow issues. Technical analysis shows positive momentum, while the earnings call provided a mixed outlook with strong growth but rising costs. Valuation remains a concern due to negative earnings.
Positive Factors
Customer Expansion
The expansion of customer wins, including but not limited to AMD, for AI/chiplet IP featuring higher ASPs is a promising indicator for future growth prospects.
Record Performance Indicators
Record annual contract value plus royalties and strong free cash flow generation indicate strong underlying demand for Arteris' network-on-chip IP solutions.
Strategic Partnerships
Arteris announced a strategic win with AMD, which will utilize its FlexGen NoC IP to provide high-performance data transport in AMD chiplets.
Negative Factors
Economic Uncertainty
Wider full-year guidance has been given due to economic uncertainty, potentially seen as overly conservative.
Profitability Challenges
Near-term profitability will continue to be sacrificed for growth with the company's non-GAAP operating loss guidance worsening, partially due to FX.
Royalty Revenue Decline
Lower-than-modeled royalty revenue has resulted in a slight downside flowing through into the upcoming quarter guidance.

Arteris (AIP) vs. SPDR S&P 500 ETF (SPY)

Arteris Business Overview & Revenue Model

Company DescriptionArteris (AIP) is a leading provider of interconnect and IP solutions for system-on-chip (SoC) design, primarily serving markets such as automotive, artificial intelligence, machine learning, and consumer electronics. The company's flagship products are its network-on-chip (NoC) interconnect IP and associated software tools, which enable efficient and scalable SoC design, enhancing performance while reducing power consumption and cost.
How the Company Makes MoneyArteris makes money primarily by licensing its intellectual property (IP) solutions to semiconductor and electronic device manufacturers who integrate these solutions into their SoC designs. The company charges upfront licensing fees as well as royalties based on the production volume of chips that incorporate its IP. Additionally, Arteris offers maintenance and support services, which provide recurring revenue streams. Strategic partnerships with major semiconductor companies and technology firms also contribute to Arteris' revenue by expanding its market reach and fostering innovation in its product offerings.

Arteris Earnings Call Summary

Earnings Call Date:Aug 05, 2025
(Q2-2025)
|
% Change Since: -27.08%|
Next Earnings Date:Nov 11, 2025
Earnings Call Sentiment Positive
The earnings call highlighted strong revenue growth, record-high annual contract values, and strategic wins with major customers like AMD, underscoring a positive business outlook. However, challenges such as increased operating expenses and negative free cash flow were noted, primarily due to foreign exchange impacts.
Q2-2025 Updates
Positive Updates
Record-High Annual Contract Value Plus Royalties
Arteris achieved a record annual contract value plus royalties of $69.1 million, representing a 15% year-over-year increase.
Strong Remaining Performance Obligations
The company exited the second quarter with $99.3 million in remaining performance obligations, marking a 28% year-over-year increase.
Revenue Growth
Total revenue for the second quarter was $16.5 million, up 13% year-over-year and at the top end of the guidance range.
AI Engineering Innovation Award
Arteris' FlexGen technology won the AI Engineering Innovation Award at the 8th Annual AI Breakthrough Awards.
Strategic Win with AMD
AMD, a top semiconductor company, signed an agreement to utilize Arteris FlexGen technology, highlighting a significant strategic win.
Negative Updates
Increased Operating Expenses
Non-GAAP operating expenses were $18.6 million, a 10% year-over-year increase, with total GAAP operating expenses increasing by 12% year-over-year.
Negative Free Cash Flow
The company reported a negative free cash flow of $2.8 million for the second quarter.
Foreign Exchange Impact on Operating Loss
The weakening U.S. dollar, especially against the euro, contributed to higher operating expenses and impacted non-GAAP operating loss guidance.
Company Guidance
During the Arteris Second Quarter 2025 Earnings Call, guidance for the third quarter and full year of 2025 was provided, detailing several key financial metrics. For the third quarter, Arteris anticipates annual contract value (ACV) plus royalties to be in the range of $69.5 million to $72.5 million, with revenue projected between $16.8 million and $17.2 million. Non-GAAP operating loss is expected to be $3 million to $4 million, while non-GAAP free cash flow is projected between $0.5 million and $3.5 million. For the full year, ACV plus royalties are expected to exit 2025 between $72 million and $78 million, with revenue ranging from $66 million to $70 million. The company also anticipates a non-GAAP operating loss of $10.5 million to $15.5 million and non-GAAP free cash flow between $1 million and $7 million. The guidance reflects the impact of foreign exchange fluctuations, particularly the weakening U.S. dollar, and underscores the company's encouraging deal execution and growing customer interest in outsourcing system IP needs to Arteris.

Arteris Financial Statement Overview

Summary
Arteris shows revenue growth but faces significant challenges in profitability and financial stability. The high gross profit margin is positive, yet negative net income and equity raise concerns about long-term viability. Cash flow management needs improvement to support financial stability.
Income Statement
45
Neutral
Arteris shows a consistent revenue growth trend, with a TTM revenue growth rate of 3.14%. However, the company is struggling with profitability, as evidenced by negative net profit margins and EBIT margins. The gross profit margin remains high at 89.21%, indicating efficient cost management relative to revenue. Overall, the income statement reflects growth potential but significant challenges in achieving profitability.
Balance Sheet
30
Negative
The balance sheet reveals a concerning financial structure with negative stockholders' equity, leading to a negative debt-to-equity ratio. The return on equity is also negative, indicating losses relative to equity. The equity ratio is not directly calculable due to negative equity, highlighting financial instability. These factors suggest a high-risk financial position with potential solvency issues.
Cash Flow
40
Negative
Cash flow analysis shows negative operating and free cash flows, with a significant decline in free cash flow growth. The operating cash flow to net income ratio is low, indicating challenges in converting income into cash. However, the free cash flow to net income ratio is relatively stable, suggesting some ability to manage cash relative to net losses. Overall, cash flow management needs improvement to support financial stability.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue63.24M57.72M53.67M50.38M37.86M31.81M
Gross Profit56.29M51.76M48.59M46.10M34.13M30.32M
EBITDA-24.45M-24.83M-28.52M-25.35M-20.27M-1.25M
Net Income-33.14M-33.64M-36.87M-27.10M-23.38M-3.26M
Balance Sheet
Total Assets106.88M106.14M102.80M115.52M120.44M42.74M
Cash, Cash Equivalents and Short-Term Investments38.05M43.84M41.17M68.15M85.83M11.74M
Total Debt7.36M5.99M7.75M3.62M3.91M4.77M
Total Liabilities114.41M107.32M87.70M77.98M67.54M54.74M
Stockholders Equity-7.53M-1.19M15.10M37.53M52.90M-12.01M
Cash Flow
Free Cash Flow-1.75M-1.04M-17.23M-7.82M-1.62M1.51M
Operating Cash Flow-1.13M-720.00K-15.73M-6.77M-814.00K2.16M
Investing Cash Flow-5.99M970.00K-4.69M-37.48M-1.36M-5.15M
Financing Cash Flow1.09M-262.00K-2.92M-4.15M76.25M790.00K

Arteris Technical Analysis

Technical Analysis Sentiment
Positive
Last Price9.48
Price Trends
50DMA
9.28
Positive
100DMA
8.12
Positive
200DMA
8.70
Positive
Market Momentum
MACD
0.10
Positive
RSI
48.62
Neutral
STOCH
13.91
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AIP, the sentiment is Positive. The current price of 9.48 is below the 20-day moving average (MA) of 9.77, above the 50-day MA of 9.28, and above the 200-day MA of 8.70, indicating a neutral trend. The MACD of 0.10 indicates Positive momentum. The RSI at 48.62 is Neutral, neither overbought nor oversold. The STOCH value of 13.91 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AIP.

Arteris Risk Analysis

Arteris disclosed 66 risk factors in its most recent earnings report. Arteris reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Arteris Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
$306.43M21.0823.09%6.31%-9.22%-13.57%
61
Neutral
$36.30B7.26-7.27%1.97%7.74%-7.92%
59
Neutral
$564.20M19.55-3.34%-10.95%-111.40%
56
Neutral
$1.01B-36.20%-7.49%-64.33%
51
Neutral
$404.32M-1369.57%18.64%16.54%
49
Neutral
$272.47M-0.92%-6.09%97.33%
46
Neutral
$384.36M-1405.64%-10774.57%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AIP
Arteris
9.39
1.86
24.70%
AEHR
Aehr Test Systems
18.31
3.63
24.73%
NVEC
NVE
63.01
-13.57
-17.72%
INDI
indie Semiconductor
4.52
0.37
8.92%
BZAI
Blaize Holdings
3.65
-7.56
-67.44%
XPER
Xperi Inc
5.91
-1.64
-21.72%

Arteris Corporate Events

Executive/Board ChangesShareholder Meetings
Arteris Holds Annual Stockholders Meeting, Elects Directors
Neutral
Jun 6, 2025

On June 3, 2025, Arteris, Inc. held its Annual Meeting of Stockholders where two key proposals were voted upon. The stockholders elected two Class I directors, K. Charles Janac and S. Atiq Raza, to serve until the 2028 annual meeting, and ratified Deloitte & Touche, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.

The most recent analyst rating on (AIP) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Arteris stock, see the AIP Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 07, 2025